Jerry Rosenbaum, MD is the Psychiatrist-in-Chief Emeritus of the Department of Psychiatry at Mass General, Director of the Center for the Neuroscience of Psychedelics, and the Stanley Cobb Professor in Psychiatry, Harvard Medical School. His research contributions include extensive leadership in the design and implementation of trials to develop innovative treatments for major depression, studies of psychopathology including comorbidity and subtypes, and studies of longitudinal course and outcomes of these psychiatric disorders. His research now focuses on understanding how psychedelics change the brain and to explore novel mechanisms for treatment of psychiatric disorders.
-
Recent clinical trials evaluating the efficacy of MDMA for PTSD highlight the need for guidelines on how to best assess the efficacy of psychedelic medicines. -
Research at the Center for the Neuroscience of Psychedelics will focus on understanding how psychedelics enhance the brain’s capacity for change, with the goal of […] -
The atai Fellowship within the Center for the Neuroscience of Psychedelics will provide graduate students with the resources to pursue cutting-edge research on therapeutic psychedelics […] -
Research at the Center for the Neuroscience of Psychedelics will focus on understanding how psychedelics enhance the brain’s capacity for change, with the goal of […] -
The Child Behavior Checklist can be used to identify children at increasing risk for developing major depression.